Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Lentinula edodes mycelia, commonly known as the mycelium of the shiitake mushroom, has been investigated for its immunomodulatory properties, which is relevant to autoimmune disorders. The primary bioactive component, lentinan, is a beta-glucan that has demonstrated immune-modulating effects in preclinical studies. Lentinan can activate macrophages, enhance natural killer (NK) cell activity, and modulate cytokine production, which theoretically could help balance abnormal immune responses seen in autoimmune diseases. Several animal studies and limited human trials suggest potential benefits in modulating immune function, though most clinical research has focused on lentinan as an adjunct therapy in oncology rather than on autoimmune diseases specifically.

While some traditional medicine systems, especially in East Asia, have used shiitake mushrooms for general immune support, the use of purified mycelial extracts or lentinan for autoimmune conditions is primarily supported by modern scientific inquiry rather than deep historical precedent. However, the quality and quantity of human evidence directly evaluating its efficacy in treating specific autoimmune disorders (such as rheumatoid arthritis, lupus, or multiple sclerosis) is still limited, and concerns remain about the risk of overstimulating the immune system in autoimmune patients. Thus, while there is a scientific rationale and preliminary evidence for immunomodulation, robust clinical data are lacking. Overall, the evidence is promising but not conclusive, justifying a moderate evidence rating.

More about Lentinula edodes mycelia
More about Autoimmune Disorders

Other ingredients used for Autoimmune Disorders

Other health conditions supported by Lentinula edodes mycelia

Products containing Lentinula edodes mycelia

Douglas Laboratories A.H.C.C. ® Plus